Mark Fishman

Mark is a Co-Founder and Chair of the Scientific Advisory Board at Aditum Bio. Prior to this, Mark was the Founding President at the Novartis Institutes for Biomedical Research (NIBR) (2002-2016). Mark is currently a Professor of Stem Cell and Regenerative Biology at Harvard. During his tenure, NIBR discovered and brought through successful early clinical trials 90 new medicines in more than 120 indications. Prior to Novartis, while Chief of Cardiology and Director of the Cardiovascular Research Center at Harvard Medical School and the MGH, Dr. Fishman’s research helped to introduce the zebrafish as a genetic model organism.

Dr. Fishman is a member of the National Academy of Medicine and a fellow of the American Academy of Arts and Sciences. In addition to his publications in developmental biology and drug discovery, Dr. Fishman is the author of the textbook ‘Medicine’ and the textbook ‘Lab’, an architecture book on how to design buildings for scientists.

Dr. Fishman graduated from Yale College and Harvard Medical School and trained in medicine and cardiology at the MGH.